Methods and devices for use of degassed fluids with fluid enhanced ablation devices

Inventors

Curley, Michael G.

Assignees

Thermedical Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11135000-B2

Patent

Publication Date

2021-10-05

Expiration Date


Abstract

Devices, systems, and methods for degassing fluid prior to applying fluid to a treatment site during ablation therapy are provided. In one embodiment, an ablation system can include an elongate body, an ablation element, a heating assembly, and a fluid source. Fluid in the fluid source can be at least partially degassed prior to being provided as part of the system, or, in some embodiments, a degassing apparatus can be provided that can be configured to degas fluid within the system prior to applying the fluid to the treatment site. The degassing apparatus can include one or more gas-permeable and fluid-impermeable tubes disposed therein, which can allow gas to be removed from fluid passing through the apparatus. Other exemplary devices, systems, and methods are also provided.

Core Innovation

The invention relates to ablating tissue by contacting tissue with an elongate body and delivering, through an inner lumen and out a distal portion of the elongate body, a fluid that is at least partially degassed. The delivered fluid contains one or more gases having less than a predetermined partial pressure, and energy is delivered to an ablation element to ablate the contacted tissue.

The problem addressed is that dissolved gases in fluid can come out of solution during heating during fluid-enhanced ablation. This gas-out-of-solution behavior can create bubbles that affect bubble compliance and pump flow, thereby reducing reliability and potentially producing adverse patient effects.

To address this, a fluid source provides at least partially degassed fluid either pre-degassed or degassed in-system, including via a degassing apparatus. Degassing can be performed by chemical treatment, boiling, vacuum exposure, or exposure to a gas source with a predetermined partial pressure/mixture.

In a mass-exchanger embodiment, gas-permeable and fluid-impermeable tubes are used, with gas ports connected to a vacuum source or a gas source, optionally with an oxygen sensor. Experimental results indicate that degassed saline provides larger and less variable lesion diameters across temperature and RF power settings compared with regular saline, with greater disparity at higher power and temperature.

Claims Coverage

Two independent claims are identified. They cover tissue ablation using an elongate body with at least partially degassed fluid delivered through an inner lumen, and a related method using a mass exchanger to degas fluid prior to delivery and ablation energy delivery.

At least partially degassed fluid delivered through inner lumen for ablation

Contacting tissue with an elongate body; delivering through an inner lumen of the elongate body and out of a distal portion a fluid that is at least partially degassed such that the fluid contains one or more gases having less than a predetermined partial pressure; and delivering energy to an ablation element to ablate the tissue in contact with the elongate body.

Mass exchanger degassing and heated tissue ablation

Contacting tissue with an elongate body; delivering fluid from a fluid source through a mass exchanger to at least partially degas the fluid; delivering the at least partially degassed fluid from a distal portion of the elongate body; and delivering energy to an ablation element to heat the tissue in contact with the elongate body.

The claim set centers on fluid-enhanced tissue ablation with control of gas content by delivering at least partially degassed fluid having less than a predetermined partial pressure, including through a mass exchanger that degasses the fluid from a fluid source before distal delivery and energy delivery to an ablation element.

Stated Advantages

Improved lesion diameter performance, including larger and less variable lesion diameters across temperature and RF power settings compared with regular saline.

Reduced variability of lesion diameters, with greater disparity between degassed and regular saline at higher power and temperature.

Documented Applications

Fluid-enhanced ablation (e.g., SERF™) involving ablation systems having an elongate body with an inner lumen and outlet ports, an ablation element, and a heating assembly for heating degassed fluid.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.